New European toolkit launched by EU agencies to help eliminate viral hepatitis B and C in prisons
Reports and Proceedings
Updates every hour. Last Updated: 7-Aug-2025 23:11 ET (8-Aug-2025 03:11 GMT/UTC)
It is already well-known that when a mother experiences inflammation during pregnancy, her child is more likely to develop allergic diseases. Recently, a KAIST research team became the first in the world to discover that inflammation within the placenta affects the fetus's immune system, leading to the child exhibiting excessive allergic reactions after birth. This study presents a new possibility for the early prediction and prevention of allergic diseases such as pediatric asthma.
KAIST (President Kwang Hyung Lee) announced on the 4th of August that a research team led by Professor Heung-kyu Lee from the Department of Biological Sciences found that inflammation occurring during pregnancy affects the fetus's stress response regulation system through the placenta. As a result, the survival and memory differentiation of T cells (key cells in the adaptive immune system) increase, which can lead to stronger allergic reactions in the child after birth.
In this regard, Zohour Ibrahim Rashwan et al. from the University of Bahrain, Zarak Bahrain, Kingdom of Bahrain, published an article entitled "Effect of empowerment-based interventions on self-efficacy" in the International Journal of Nursing Sciences. interventions on self-efficacy and self care capacity among patients with sickle cell disease: a randomized controlled trial" in the International Journal of Nursing Sciences. A randomized controlled trial was conducted to systematically investigate the effectiveness of empowerment-based interventions in this population and to provide new ideas and rationale for nursing practice for patients with SCD.
This study investigated the efficacy of a novel oral formulation combining golden tomato extract, niacinamide, yeast extract (glutathione), and astaxanthin in improving skin hydration, pigmentation, and overall appearance. A randomized, double-blind, parallel-controlled trial was conducted with 62 healthy female participants over eight weeks. The treatment group consumed the WONDERLAB® Tomato Niacinamide Beverage, while the placebo group received no active ingredients. After eight weeks, significant improvements were observed in the treatment group. Stratum corneum hydration increased by 35.63%, and transepidermal water loss (TEWL) decreased by 29.39%, reflecting enhanced skin barrier function. Skin gloss improved by 18.59%, color uniformity by 15.03%, and overall skin tone lightened, as shown by a 6.36% increase in ITA value. Moreover, systemic antioxidant markers demonstrated positive changes, with elevated levels of superoxide dismutase (SOD) and glutathione peroxidase (GPx), alongside reduced malondialdehyde (MDA) levels, indicating lower oxidative stress. The findings confirm that continuous intake of this tomato extract formulation not only visibly improves skin hydration and whitening but also enhances internal antioxidant defense, providing dual protection against skin aging and pigmentation.